Ongoing projects

Research Project Title

Acronym

Data controller

Lawfulness of processing

Recipients of the data

Data retention period

Category of data

Transfer outside the EU

Matching of the FREGAT clinical and biological database with the SNDS

FREGAT-Link

CHU de Lille

Public interest

Academic

3 years after completion of research

Clinical data

No

Role of socioeconomic and environmental inequalities on esogastric cancers

INEKOG

Lille university, UMR CNRS 9221

Public interest

Academic

Completion of research

Clinical data - Questionnaires

No

Understanding the molecular mechanisms associated with tumor resistance in gastric adenocarcinoma

miniPRESTO

Institut régional du cancer de Montpellier

Public interest

Academic

Completion of research

Clinical data – Tumour samples

No

Biological analyses and response to therapy of esogastric adenocarcinomas with microsatellite instability

ARTEMSI

CHU de Lille

Public interest

Academic

Completion of research

Clinical data – Tumour samples

No

MS Guide surgery for gastric cancer

MS Guide

Lille university / INSERM U1192

Public interest

Academic

Completion of research

Clinical data – Tumour samples

No

Development of a statistical model for the prediction of MSI status from digitized H&E slides of tumor tissue

MSI-IA

CHU de Lille

Public interest

Academic

Completion of research

Clinical data – Tumour samples

No

Using artificial intelligence to predict the molecular subtype and oncologic outcome of patients with adenocarcinoma of the stomach

FREGANET

CHU de Lille

Public interest

Academic

Completion of research

Clinical data – Tumour samples

No

Using artificial intelligence to predict the molecular subtype and oncologic outcome of patients with esophageal adenocarcinoma

FREGATIA

CHU de Lille

Public interest

Academic

Completion of research

Clinical data – Tumour samples

No

The presence of metastatic lymph nodes in esogastric adenocarcinoma: a definitive contraindication to surgery?

OMEGA

Association pour l’étude des maladies digestives

Public interest

Academic

Completion of research

Clinical data

No

Effects of centralization of cancer care on patients' quality of life. Analysis and perspectives from the FREGAT cohort (oesogastric cancers).

CENTRAVIE

Centre Léon Bérard

Public interest

Academic

Completion of research

Clinical data - Questionnaires

No

Disease burden, epidemiology, treatment patterns and healthcare resource utilization in France for locally advanced unresectable or metastatic adenocarcinoma of gastric and gastroesophageal Junction (G/GEJ): an analysis using the FREGAT Database

BECOME

Astellas

Public interest

Industrial

Completion of research

Clinical data

No

Feasibility and efficacy of perioperative treatment in patients over 75 years managed for localized adenocarcinoma of the stomach or GEJ.

STOMAGE

CHU de Lille

Public interest

Academic

Completion of research

Clinical data - Questionnaires

No

Defining Predictive Immunedeterminants of response to neoadjuvant Chemoradiation in Oesophageal adenocarcinoma.

PREDICO

San Raffaele Scientific Institute (Italy)

Public interest

Academic

Completion of research

Clinical data – Biopsies - Blood samples

No

Dissecting metabolic heterogeneity in oesophageal cancer to increase immunotherapy efficacy and overcome resistance

IMPROVE

Institut Pasteur Lille

Public interest

Academic

Completion of research

Clinical data – Biopsies

No

Real world management and outcomes of patients with non-metastatic esophageal squamous cell carcinoma in the FREGAT database

2024-01

CHU de Lille

Public interest

Academic

Completion of research

Clinical data

No

Determination of microbiological factors predictive of response to neoadjuvant therapy in non-metastatic esophageal adenocarcinoma and esogastric junction

MICADOE

CHU de Lille

Public interest

Academic

Completion of research

Clinical data

No

Circulating biomarker signatures for the detection of preneoplastic lesions and gastric cancer.

PREGASIGN

Institut Pasteur

Public interest

Academic

Completion of research

Clinical data - Blood samples

No

EBV + and Gastric Cancer

EBV Estomac

Association des Gastroentérologues Oncologues (AGEO)

Public interest

Academic

Completion of research

Clinical data

No

Evaluation of the administration of artificial nutrition by feeding jejunostomy during neoadjuvant treatment on postoperative morbidity in the context of esophageal or gastric cancer

FREJENO

CHU de Bordeaux

Public interest

Academic

2 years following the last publication of research results

Clinical data

No

Prediction of severe postoperative complications after esogastric surgery using deep learning models, applied to the national FREGAT database

PREDICT-EGS

Laboratoire SYNERGIES

Public interest

Academic

2 years following the last publication of research results

Clinical data

No

Mode of onset of peritoneal carcinomatosis in gastric cancers in Lille over 10 years and selection for surgery

GASTRILILLE

CHU de Lille

Public interest

Academic

2 years following the last publication of research results

Clinical data

No

Postoperative and oncological outcomes of the minimally invasive approach in gastric cancer in France: a retrospective comparative study from the FREGAT database (based on a composite endpoint: TEXTBOOK outcome)

TEXTBOOK outcome

CHU de Lille

Public interest

Academic

2 years following the last publication of research results

Clinical data

No

Validation of a predictive calcium score for the risk of anastomotic leak after oncological esophageal surgery

OESOCALCISCORE

CHU de Limoges

Public interest

Academic

2 years following the last publication of research results

Clinical data

No

Evaluation of the evolution of quality of life during the surgical management of cardia cancers – Trajectory and Impact on Quality of life in Oesogastric cancer over time

TIME-QOG

AP-HP

Public interest

Academic

2 years following the last publication of research results

Clinical data

No

Characterization of the Response Evaluated by transcriptomic Signatures for Chemotherapies and Immunotherapies in esogastric Adenocarcinoma.

CRESCENDO

CHU de Lille

Public interest

Academic

2 years following the last publication of research results

Clinical data

No

SarcopenIa in Gastric cancer iMpact Assessment

SIGMA

CHU de Rennes

Public interest

Academic

2 years following the last publication of research results

Clinical data

No